PUBLICATIONS · 21247627
Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Lancet
- Publication date
- 2011 Jan 22
- First author
- van de Velde CJ
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Lancet. 2011 Jan 22;377(9762):280-1. doi: 10.1016/S0140-6736(11)60073-1.
- note
- Source null
- related pmid
- 21256370
- relationship
- Comment in
Authors and identifiers
- name
- van de Velde CJ
- type
- Author
- name
- Rea D
- type
- Author
- name
- Seynaeve C
- type
- Author
- name
- Putter H
- type
- Author
- name
- Hasenburg A
- type
- Author
- name
- Vannetzel JM
- type
- Author
- name
- Paridaens R
- type
- Author
- name
- Markopoulos C
- type
- Author
- name
- Hozumi Y
- type
- Author
- name
- Hille ET
- type
- Author
- name
- Kieback DG
- type
- Author
- name
- Asmar L
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- van de Velde CJ
- type
- Author
- name
- Rea D
- type
- Author
- name
- Seynaeve C
- type
- Author
- name
- Putter H
- type
- Author
- name
- Hasenburg A
- type
- Author
- name
- Vannetzel JM
- type
- Author
- name
- Paridaens R
- type
- Author
- name
- Markopoulos C
- type
- Author
- name
- Hozumi Y
- type
- Author
- name
- Hille ET
- type
- Author
- name
- Kieback DG
- type
- Author
- name
- Asmar L
- type
- Author
- bibliography ids
- nci-bib-6b58ee1b082115419628aabe
- book metadata
- content sha256
- 117ab87bd69ad5a28d5384f33e6eebc038198db8ef886a3c22526d5db72c2d56
- document type
- citation
- dois
- 10.1016/S0140-6736(10)62312-4
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:21247627
- immutable id
- pubmed:21247627@117ab87bd69ad5a28d5384f33e6eebc038198db8ef886a3c22526d5db72c2d56
- journal
- abbreviation
- Lancet
- issn electronic
- 1474-547X
- issn print
- 0140-6736
- issue
- 9762
- name
- Lancet (London, England)
- nlm unique id
- 2985213R
- pages
- 321-31
- volume
- 377
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Lancet. 2011 Jan 22;377(9762):280-1. doi: 10.1016/S0140-6736(11)60073-1.
- note
- Source null
- related pmid
- 21256370
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 21247627
- provenance
- batch id
- edef4b7f1a2a505cd5a9
- provider
- NCBI PubMed ESummary
- record sha256
- 4d1fe6289c4d55e1db4a55a48891de2b5ef59ced861fbff731403626f717ad6a
- response sha256
- d2d0fd7c34783716c953156f8a1da1b7b36c4823b416656eca04a1e69e03a295
- retrieved at
- 2026-09-09T23:46:38.027615+00:00
- publication date
- display
- 2011 Jan 22
- precision
- day
- year
- 2011
- publication types
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial.
Preserved source evidence · Not medical advice
Triangle